With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's take a look.

The Moderna Inc (NASDAQ: MRNA) share price went like gangbusters yesterday, overnight Aussie time. The US biotech company's share price leapt 10.8%. And its up another 3.8% in afterhours trading.

This comes as investors eagerly anticipate the outcome of the final analysis of Moderna's promising COVID-19 vaccine trial.

Earlier this month, Moderna joined Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in a globally exclusive club when the company announced its vaccine looked to be 95% effective in its extensive trial. One which encompassed 30,000 people.

Moderna's share price is now up 62% so far in November, and 468% so far in 2020. At the current share price, Moderna has a market cap of $48 billion.

small figure representing ASX shares with cape and shield fighting coronavirus

Image source: Getty Images

What does Moderna do?

Based in the United States city of Cambridge, Massachusetts, Moderna is a biotechnology company. The company focuses on developing and discovering new drugs and vaccine technologies based on messenger RNA. Moderna's technology platform inserts synthetic mRNA into human cells.

Why did the Moderna's share price leap 11% overnight?

Moderna's share price has been steadily moving higher on a series of positive announcements from the company.

Among those, the US has committed to buying 100 million doses of its vaccine, mRNA-1273, provided it wins emergency use approval. And it's not just the US.

Japan has agreed to buy 50 million doses, Canada wants 20 million and, in the latest development, the European Commission agreed to buy 80 million doses with an option to double that to 160 million. That agreement remains subject to European approval of the vaccine.

The 10.8% share price leap overnight comes as Moderna expects to release the final data from its expansive trial within the next week. Should the vaccine's efficacy prove to be in the 94.5% range as initially reported, Moderna will then file for emergency use authorisation with the US Food and Drug Administration (FDA).

If it gains approval, Moderna's vaccine could begin mass distribution just as global infection rates are rocketing to new levels. Hence the big share price surge.

Share markets are said to be forward looking. Meaning they anticipate tomorrow's news today.

With more than 588,000 new infections reported on Tuesday, 24 March, and global cases exceeding 60.2 million with 1.4 million fatalities, let's all hope the market's got this one right!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild, but ultimately positive, Tuesday for investors.

Read more »

Rocket going up above mountains, symbolising a record high.
Share Gainers

Invested $5,000 in Dateline shares a week ago? Here's how much you'd have now

It's been a huge week for Dateline shares.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy start to the week's trading today.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a sour end to the trading week for investors this Friday.

Read more »

Drone flying in the sky.
Share Gainers

EOS shares jump 7% as ASX 200 falls. Could $15 be next?

Could this ASX defence stock have much further to run?

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough Thursday for investors this session.

Read more »

AI microprocessor on motherboard computer circuit.
AI Stocks

If I'd invested $5,000 in this ASX AI stock 6 months ago, I'd have $113,750 today!

Up 2,175% in six months, this ASX AI stock is forecast to keep charging higher. But why?

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild, but positive, Wednesday for investors.

Read more »